Bionime マネジメント
マネジメント 基準チェック /14
Bionime's CEO is Roy Huang, appointed in Jan 2002, has a tenure of 22.83 years. directly owns 5.95% of the company’s shares, worth NT$260.71M. The average tenure of the management team and the board of directors is 6 years and 2.8 years respectively.
主要情報
Roy Huang
最高経営責任者
n/a
報酬総額
| CEO給与比率 | n/a |
| CEO在任期間 | 22.8yrs |
| CEOの所有権 | 6.0% |
| 経営陣の平均在職期間 | 6yrs |
| 取締役会の平均在任期間 | 2.8yrs |
経営陣の近況
Recent updates
Bionime (TWSE:4737) Is Reducing Its Dividend To NT$2
Jul 22
Bionime (TWSE:4737) Will Pay A Smaller Dividend Than Last Year
Jul 01These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong
Apr 29Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?
Mar 23Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?
Mar 05Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?
Feb 15
Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet
Feb 01How Has Bionime (TPE:4737) Allocated Its Capital?
Jan 19A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE
Jan 06A Look At The Fair Value Of Bionime Corporation (TPE:4737)
Dec 22Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend
Dec 09Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment
Nov 24CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -NT$40m |
| Mar 31 2024 | n/a | n/a | NT$7m |
| Dec 31 2023 | n/a | n/a | NT$6m |
| Sep 30 2023 | n/a | n/a | NT$22m |
| Jun 30 2023 | n/a | n/a | NT$43m |
| Mar 31 2023 | n/a | n/a | NT$72m |
| Dec 31 2022 | n/a | n/a | NT$91m |
| Sep 30 2022 | n/a | n/a | NT$95m |
| Jun 30 2022 | n/a | n/a | NT$115m |
| Mar 31 2022 | n/a | n/a | NT$89m |
| Dec 31 2021 | NT$4m | NT$4m | NT$87m |
| Sep 30 2021 | n/a | n/a | NT$101m |
| Jun 30 2021 | n/a | n/a | NT$111m |
| Mar 31 2021 | n/a | n/a | NT$83m |
| Dec 31 2020 | NT$4m | NT$4m | NT$62m |
| Sep 30 2020 | n/a | n/a | NT$73m |
| Jun 30 2020 | n/a | n/a | NT$38m |
| Mar 31 2020 | n/a | n/a | NT$91m |
| Dec 31 2019 | NT$5m | NT$4m | NT$106m |
報酬と市場: Insufficient data to establish whether Roy's total compensation is reasonable compared to companies of similar size in the TW market.
報酬と収益: Roy's compensation has increased whilst the company is unprofitable.
CEO（最高経営責任者
Roy Huang
22.8yrs
在職期間
NT$4,429,000
報酬
Mr. Chun-Mu Huang also known as Roy, founded Bionime Corporation in 2002. Mr. Huang serves as Chairman and General Manager of Bionime Corporation and has been its Director since April 14, 2003. He Complete...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | 22.8yrs | NT$4.43m | 5.95% NT$ 260.7m | |
| Manager of Human Resources Department & Financial Officer | less than a year | データなし | データなし | |
| Assistant General Manager of Operation Division | 8.8yrs | データなし | データなし | |
| Assistant GM of Administration Division & Corporate Governance Officer | 1.5yrs | データなし | データなし | |
| Vice President of Research and Development | no data | データなし | データなし | |
| Assistant General Manager of Sales Division | 6yrs | データなし | データなし | |
| Assistant General Manager of Marketing Planning Division | 6yrs | データなし | データなし |
6.0yrs
平均在職期間
経験豊富な経営陣: 4737's management team is seasoned and experienced (6 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | 21.6yrs | NT$4.43m | 5.95% NT$ 260.7m | |
| Representative Director | 5.4yrs | NT$533.00k | データなし | |
| Representative Director | 2.8yrs | データなし | データなし | |
| Independent Director | no data | データなし | データなし | |
| Independent Director | no data | データなし | 0.16% NT$ 6.9m | |
| Independent Director | no data | データなし | 0.048% NT$ 2.1m | |
| Director | 2.8yrs | データなし | データなし | |
| Additional Independent Director | 1.4yrs | データなし | 0.45% NT$ 19.5m |
2.8yrs
平均在職期間
経験豊富なボード: 4737's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.